116 related articles for article (PubMed ID: 7249281)
21. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
Stimler NP; O'Flaherty JT
Am J Pathol; 1983 Oct; 113(1):75-84. PubMed ID: 6624879
[TBL] [Abstract][Full Text] [Related]
22. The effects of aspirin and hypothermia on platelet function in vivo.
Michelson AD; Barnard MR; Khuri SF; Rohrer MJ; MacGregor H; Valeri CR
Br J Haematol; 1999 Jan; 104(1):64-8. PubMed ID: 10027713
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
24. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
Ali M; McDonald JW
J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
[TBL] [Abstract][Full Text] [Related]
25. Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance.
Carroll RC; Worthington RE; Craft RM; Snider CC; Dakin PA; Wortham DC; Scott J; Jarrett A
Thromb Res; 2010 Apr; 125(4):e118-22. PubMed ID: 19962724
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Del Maschio A; Livio M; Cerletti C; De Gaetano G
Eur J Pharmacol; 1984 Jun; 101(3-4):209-14. PubMed ID: 6432556
[TBL] [Abstract][Full Text] [Related]
27. Role of pulmonary intravascular macrophages in anti-platelet serum-induced pulmonary hypertension in sheep.
Nakano T; Miyamoto K; Nishimura M; Aida A; Aoi K; Kawakami Y
Respir Physiol; 1994 Sep; 98(1):83-99. PubMed ID: 7817044
[TBL] [Abstract][Full Text] [Related]
28. Role of platelets in maintenance of pulmonary vascular permeability to protein.
Lo SK; Burhop KE; Kaplan JE; Malik AB
Am J Physiol; 1988 Apr; 254(4 Pt 2):H763-71. PubMed ID: 3354701
[TBL] [Abstract][Full Text] [Related]
29. Thromboxane production in the pregnant rat: differential recovery by platelets and uterus following aspirin administration.
Dubin NH; Ghodgaonkar RB; Blake DA
Biol Reprod; 1983 Oct; 29(3):743-9. PubMed ID: 6626652
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous injury in isolated sheep lungs: role of perfusate leukocytes and platelets.
Pearse DB; Brower RG; Adkinson NF; Sylvester JT
J Appl Physiol (1985); 1989 Mar; 66(3):1287-96. PubMed ID: 2708249
[TBL] [Abstract][Full Text] [Related]
31. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.
Addonizio VP; Fisher CA; Jenkin BK; Strauss JF; Musial JF; Edmunds LH
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):926-33. PubMed ID: 2582210
[TBL] [Abstract][Full Text] [Related]
32. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate.
Hernández R; Alemany M; Bozzo J; Buchanan MR; Ordinas A; Bastida E
Haemostasis; 1993; 23(1):1-7. PubMed ID: 8477903
[TBL] [Abstract][Full Text] [Related]
33. Effects of clopidogrel and aspirin on platelet aggregation, thromboxane production, and serotonin secretion in horses.
Brainard BM; Epstein KL; LoBato D; Kwon S; Papich MG; Moore JN
J Vet Intern Med; 2011; 25(1):116-22. PubMed ID: 21143302
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
Karmazyn M; Moffat MP; Beamish RE; Dhalla NS
J Pharmacol Exp Ther; 1981 Sep; 218(3):764-70. PubMed ID: 6894943
[No Abstract] [Full Text] [Related]
35. Thromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator.
Addonizio VP; Smith JB; Strauss JF; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1980 Jan; 79(1):91-6. PubMed ID: 7350392
[No Abstract] [Full Text] [Related]
36. Sulfinpyrazone and aspirin increase epicardial coronary collateral flow in dogs.
Davenport N; Goldstein RE; Capurro N; Lipson LC; Bonow RO; Shulman NR; Epstein SE
Am J Cardiol; 1981 Apr; 47(4):848-54. PubMed ID: 7211699
[No Abstract] [Full Text] [Related]
37. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
38. Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men.
Mohri H; Ohkubo T
Ann Pharmacother; 1993 Apr; 27(4):405-10. PubMed ID: 8477113
[TBL] [Abstract][Full Text] [Related]
39. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
[TBL] [Abstract][Full Text] [Related]
40. Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.
Mullane KM; Fornabaio D
Circ Res; 1988 Apr; 62(4):668-78. PubMed ID: 3127073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
